IndraLab

Statements

USP25 deubiquitinates APP. 1 / 1

1 |

"Similarly to what occurs with CD3delta, overexpression of USP25 increases APP half-life. Again, this effect depends on the catalytic activity of USP25, as catalytically inactive USP25(C178S) does not alter APP turnover (Figure 3B)."

22590560

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP25 deubiquitinates APP. 1 / 1

INDRA sources:

Databases

Reading